The electrophysiology of Norpace (Part II).
D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001283:Atrioventricular Node / Q000187:drug effects; D004206:Disopyramide / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D004341:Drug Evaluation; D006325:Heart Atria / Q000187:drug effects; D006327:Heart Block / Q000188:drug therapy; D006329:Heart Conduction System / Q000187:drug effects*; D006801:Humans; D011725:Pyridines / Q000494:pharmacology*; D011802:Quinidine / Q000009:adverse effects / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D011725:Pyridines; D004206:Disopyramide; D011802:Quinidine